Clinical observation of Shouwu Huoxue Granules combined with dual antiplatelet in treatment of large atherosclerotic cerebral infarction

LI Chaosheng; KONG Liang; DI Meiqi; FAN Changyan; HUI Zhen; HU Lingling

doi:10.7619/jcmp.20214791

Journal of Clinical Medicine in Practice > 2022 > 26(3): 59-62, 67. > DOI: 10.7619/jcmp.20214791

LI Chaosheng, KONG Liang, DI Meiqi, FAN Changyan, HUI Zhen, HU Lingling. Clinical observation of Shouwu Huoxue Granules combined with dual antiplatelet in treatment of large atherosclerotic cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 59-62, 67. DOI: 10.7619/jcmp.20214791

Citation:

PDF (785 KB)

Clinical observation of Shouwu Huoxue Granules combined with dual antiplatelet in treatment of large atherosclerotic cerebral infarction

Department of Neurology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000

More Information

Received Date: December 05, 2021
Available Online: March 04, 2022
Published Date: February 14, 2022

Graphical Abstract

Abstract

Abstract

Objective To observe the clinical effect of Shouwu Huoxue Granules combined with dual antiplatelet therapy in treatment of large atherosclerotic cerebral infarction (ATCI).
Methods A total of 127 ATCI patients were selected. According to the random number table method, they were divided into control group (63 cases, dual antiplatelet for treatment) and observation group (64 cases, Shouwu Huoxue granule combined dual antiplatelet for treatment), both groups were treated for 21 days; at the end of treatment, the efficacy of the two groups was evaluated and compared; the syndrome scores of the two groups were evaluated and compared before treatment and 21 days after treatment, the blood lipid levels and inflammatory indexes of the two groups were detected; the occurrence of adverse reactions during treatment of two groups was recorded.
Results The overall efficacy of the observation group was better than that of the control group, and the total effective rate was higher than that of the control group (P < 0.05); after 21 days of treatment, the syndrome scores, low density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglyceride (TG), interleukin-6 (IL-6) and C-reactive protein (CRP) levels of the observation group were lower than those of the control group (P < 0.05); the total incidence of adverse reactions of both groups showed no significant difference (P>0.05).
Conclusion The combination of Shouwu Huoxue Granules and dual antiplatelet in the treatment of ATCI patients has better effect, which reduce the levels of blood lipid and inflammatory indexes, and has high safety.
- atherosclerotic cerebral infarction,
- Shouwu Huoxue Granules,
- dual antiplatelet,
- blood lipids,
- inflammatory indexes

FullText(HTML)

References (17)

References

[1]	YAN Z, FU B S, HE D, et al. The relationship between oxidized low-density lipoprotein and related ratio and acute cerebral infarction[J]. Medicine, 2018, 97(39): e12642. doi: 10.1097/MD.0000000000012642
[2]	COLUMBO J A, LAMBOUR A J, SUNDLING R A, et al. A meta-analysis of the impact of aspirin, clopidogrel, and dual antiplatelet therapy on bleeding complications in noncardiac surgery[J]. Ann Surg, 2018, 267(1): 1-10. doi: 10.1097/SLA.0000000000002279
[3]	宁为民, 伍小玲, 杨康强, 等. 急性脑梗死中医证候学研究概况[J]. 现代中西医结合杂志, 2020, 29(11): 1232-1235. doi: 10.3969/j.issn.1008-8849.2020.11.023
[4]	高峰, 卫培峰. 基于免疫调节途径的舌草首乌颗粒辅助抗肿瘤作用机制[J]. 四川中医, 2018, 36(10): 38-41. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZY201810013.htm
[5]	中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志, 2015, 48(4): 246-257. doi: 10.3760/cma.j.issn.1006-7876.2015.04.002
[6]	郑筱萸. 中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002: 117-119.
[7]	NAESS H, KURTZ M, THOMASSEN L, et al. Serial NIHSS scores in patients with acute cerebral infarction[J]. Acta Neurol Scand, 2016, 133(6): 415-420. doi: 10.1111/ane.12477
[8]	郭笑颜, 陈伟彬, 李盖, 等. 脑梗死患者血脂水平与颈动脉粥样硬化CTA特征的相关性[J]. 临床放射学杂志, 2019, 38(2): 214-218. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFS201902006.htm
[9]	SUGAWARA M, GOTO Y, YAMAZAKI T, et al. Low-dose aspirin for primary prevention of cardiovascular events in elderly Japanese patients with atherosclerotic risk factors: subanalysis of a randomized clinical trial (JPPP-70)[J]. Am J Cardiovasc Drugs, 2019, 19(3): 299-311. doi: 10.1007/s40256-018-0313-0
[10]	DAYOUB E J, SEIGERMAN M, TUTEJA S, et al. Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016[J]. JAMA Intern Med, 2018, 178(7): 943-950. doi: 10.1001/jamainternmed.2018.0783
[11]	陈玉兰. 丹参川芎嗪注射液联合双联抗血小板治疗老年急性脑梗死的疗效观察[J]. 中西医结合心脑血管病杂志, 2020, 18(16): 2708-2711. doi: 10.12102/j.issn.1672-1349.2020.16.039
[12]	蒋亚丽, 王辉. 当归药性与功用考证[J]. 中医药导报, 2019, 25(11): 72-74, 77. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB201911019.htm
[13]	周茂平. 芪棱汤联合前列地尔对动脉粥样硬化性脑梗死患者血脂水平及神经功能的影响研究[J]. 四川中医, 2018, 36(5): 134-136.
[14]	赵月娥, 吴才标, 李育新, 等. 海南省黎族人群颈动脉粥样硬化斑块与血脂水平的相关性研究[J]. 中国医科大学学报, 2020, 49(1): 58-61, 66.
[15]	高雯华, 袁梦石, 曾倩柔, 等. 何首乌颗粒剂对阿尔茨海默病模型大鼠学习记忆及miRNA-101表达的影响[J]. 湖南中医药大学学报, 2018, 38(10): 1120-1124. doi: 10.3969/j.issn.1674-070X.2018.10.006
[16]	丁静, 骆倩. 阿托伐他汀治疗急性脑梗死对患者血清hs-CRP、IL-6、IL-8及MMP-9水平的影响[J]. 河北医药, 2019, 41(1): 85-88.
[17]	王群, 杨关林, 贾连群, 等. 基于网络药理学探讨何首乌治疗动脉粥样硬化作用机制[J]. 辽宁中医药大学学报, 2019, 21(9): 138-141. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201909040.htm

[1]	WANG Tingting, MA Huizhen, DENG Xiaolan, ZHU Huanhuan. Relationships of inflammatory indexes with frailty and early stage of frailty[J]. Journal of Clinical Medicine in Practice, 2022, 26(19): 87-91. DOI: 10.7619/jcmp.20221443
[2]	YIN Jiansong, XU Di, XUE Fei, WANG Jing, XUE Mei, JI Ping, WANG Yu. Correlation between Mycoplasma pneumoniae pneumonia and blood lipid levels in children[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 105-108. DOI: 10.7619/jcmp.20213995
[3]	WANG Xulei, LI Cuihong. Effect of butylphthalide soft capsule combined with dual antiplatelet therapy in elderly patients with acute middle cerebral ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 25-28. DOI: 10.7619/jcmp.202012007
[4]	JU Xiangli, PEI Dongmei. Correlation between prevalence of thyroid nodule and abnormal metabolism of blood glucose as well as lipid[J]. Journal of Clinical Medicine in Practice, 2020, 24(10): 53-56. DOI: 10.7619/jcmp.202010013
[5]	JIN Yunzhou, LI Mingfang, ZHENG Sheng, ZHANG Jiqin, QU Yunfei, ZHANG Jianrong. Changes of lymphocyte,interleukin-6 and inflammatory indexes in patients with coronavirus disease 2019 under different conditions of disease[J]. Journal of Clinical Medicine in Practice, 2020, 24(6): 1-4. DOI: 10.7619/jcmp.202006001
[6]	GUO Zhengping, ZHANG Hong. Effect of bronchoscopic alveolar lavage on inflammation and blood gas index in children with severe pneumonia[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 50-53. DOI: 10.7619/jcmp.202001013
[7]	WANG Yongfen, XU Danfeng. Effect of quality nursing intervention on blood lipid and high sensitivity C-reactive protein in patients with unstable angina pectoris[J]. Journal of Clinical Medicine in Practice, 2018, (2): 1-4. DOI: 10.7619/jcmp.201802001
[8]	LI Yaznou. Influence of laparoscopic operation combined with sodium hyaluronate on the adhesion and inflammatory status indexes of patients with adhesive intestinal obstruction[J]. Journal of Clinical Medicine in Practice, 2017, (1): 72-74. DOI: 10.7619/jcmp.201701021
[9]	CUI Guoxiong, LI Fei. Influence of Xuezhikang on blood lipids, inflammatory factors and carotid atherosclerotic plaques in patients with unstable angina[J]. Journal of Clinical Medicine in Practice, 2016, (23): 54-56,60. DOI: 10.7619/jcmp.201623016
[10]	LI Wei. Factors of ACS atorvastatin on blood lipid levels, serum inflammatory[J]. Journal of Clinical Medicine in Practice, 2013, (15): 56-58. DOI: 10.7619/jcmp.201315020

Cited By

Cited by

Periodical cited type(63)

1.	徐丹，余芳，任刚. 腺样体肥大患儿临床症状及肺通气功能影响因素分析. 中国妇幼保健. 2025(04): 703-706 .
2.	儿童扁桃体腺样体低温等离子射频消融术规范化治疗技术标准. 临床耳鼻咽喉头颈外科杂志. 2025(02): 97-109 .
3.	郜思远，乔孝武，杨军，彭栋梁. 艾司氯胺酮联合切口周围局部浸润麻醉对全麻腹股沟疝修补术患儿苏醒期躁动和疼痛-应激因子的影响. 海南医学. 2025(05): 693-698 .
4.	程默羽，汪旭，高峰. 低温等离子体系统治疗扁桃体、腺样体肥大的效果探讨. 中外医药研究. 2025(01): 22-24 .
5.	陈荣. 低温等离子辅助下扁桃体及腺样体切除术治疗扁桃体肥大伴腺样体肥大的疗效观察. 生命科学仪器. 2025(04): 148-150 .
6.	杨凤山. 低温等离子体系统在扁桃体/腺样体肥大患者手术治疗中的应用价值分析. 中国医学文摘(耳鼻咽喉科学). 2024(01): 27-29+46 .
7.	崔学英，宋云红. 低温等离子手术治疗扁桃体腺样体肥大的临床疗效研究. 中国医学文摘(耳鼻咽喉科学). 2024(01): 124-126 .
8.	谢婷，吴芬. 术中积极性暗示心理护理干预对扁桃体切除术患者恐惧情绪及配合度的影响. 中国医学文摘(耳鼻咽喉科学). 2024(01): 224-227 .
9.	时恩来，方怡. 低温等离子与常规电刀在软腭黏膜良性病变切除中的应用效果比较. 中国实用医药. 2024(02): 50-53 .
10.	兰泮丽，罗兰，李菲. 小儿低温等离子腺样体切除术术后出血情况及危险因素分析. 中国妇幼保健. 2024(07): 1300-1303 .
11.	王斯燕. 低温等离子体系统在扁桃体/腺样体肥大患者手术治疗中的应用价值分析. 中国医学文摘(耳鼻咽喉科学). 2024(02): 91-94 .
12.	朱金枝，张金星，陈巧婷. 鼻内镜下腺样体等离子切除术与腺样体刮除术在腺样体肥大患儿中的效果对比及对鼻腔黏膜纤毛清除功能的影响. 慢性病学杂志. 2024(04): 599-602 .
13.	陈文龙，杜志宏. 鼻内镜下低温等离子射频消融术治疗儿童扁桃体及腺样体肥大的效果评价. 现代医学与健康研究电子杂志. 2024(07): 142-144 .
14.	金名花. 预防性应用小剂量艾司氯胺酮对行扁桃体腺样体手术患儿全麻苏醒期躁动的影响. 天津药学. 2024(02): 47-50 .
15.	李峰，张萍，史欣. 鼻内镜下低温等离子切除术治疗儿童腺样体肥大的临床疗效及对患儿创伤应激和并发症的影响. 山西医药杂志. 2024(06): 418-422 .
16.	张艳，王慧. 低温等离子辅助下扁桃体及腺样体切除术治疗扁桃体肥大伴腺样体肥大患儿的疗效观察. 现代医学与健康研究电子杂志. 2024(08): 41-45 .
17.	宋云红，崔学英. 扁桃体摘除联合鼻内镜下腺样体切除治疗小儿鼾症的临床疗效. 中国医学文摘(耳鼻咽喉科学). 2024(03): 13-16 .
18.	钱金吉，林优优，林贺. 物理抗菌网液在儿童低温等离子扁桃体切除术后康复中的应用效果. 中国医药导报. 2024(15): 95-98 .
19.	陈聪梅，林小玲，卓翠芳，邓美旋. 临床护理路径在围手术期治疗患儿扁桃体伴腺样体肥大中的应用效果. 中国医药指南. 2024(16): 167-169 .
20.	王勤，杜志宏. 鼻内镜下低温等离子扁桃体腺样体切除术改善鼾症患儿临床症状的效果评价. 现代医学与健康研究电子杂志. 2024(09): 51-53 .
21.	张芬芬，潘霞. 鼻内镜辅助腺样体低温等离子消融术与电动切割器切除术治疗Ⅰ～Ⅱ度腺样体肥大患儿的效果对比. 中国妇幼保健. 2024(13): 2431-2434 .
22.	朱海燕，廖天义，廖俊丰，朱汉辉. 低温等离子射频消融术治疗小儿鼾症的效果观察. 中国内镜杂志. 2024(06): 60-66 .
23.	侍海霞. 两种切除术对扁桃体肥大伴腺样体肥大患儿围术期指标及并发症的影响. 系统医学. 2024(10): 116-119 .
24.	龙松良，张霞平. 鼻内镜下低温等离子腺样体消融术治疗小儿腺样体肥大疗效观察. 临床小儿外科杂志. 2024(06): 578-583 .
25.	徐芬芳，张帆，卢婷. 基于趣味视频互动式健康宣教用于微创疝气手术患儿对不良情绪及满意度的影响. 国际护理学杂志. 2024(14): 2625-2629 .
26.	李振刚，强学全，张宝明. 鼻内镜辅助三线减张鼻中隔矫正术治疗鼻中隔偏曲患者的效果. 医学理论与实践. 2024(15): 2599-2601 .
27.	王振勇，吴伟，梁子聪. 鼻内镜下腺样体低温等离子射频消融术治疗小儿鼾症合并腺样体肥大的效果及安全性评价. 黔南民族医专学报. 2024(02): 160-164 .
28.	孙梅英. 低温等离子射频消融术对小儿扁桃体肥大合并鼾症的疗效研究. 临床研究. 2024(08): 27-30 .
29.	邵滨峰，王佳，张世涛. 鼻内窥镜下低温等离子扁桃体和腺样体切除术配合中药超声雾化治疗儿童鼾症临床疗效. 实用中医药杂志. 2024(08): 1584-1587 .
30.	李世伟，田秀芬，窦倩雯. 微创等离子消融术在扁桃体腺样体肥大患者治疗中的应用及对其免疫能力及氧化应激水平的影响. 临床医学工程. 2024(09): 1043-1044 .
31.	周志存，林春裕. 扁桃体腺样体肥大患儿使用低温等离子扁桃体腺样体切除术进行治疗效果分析. 中国医药指南. 2024(26): 81-84 .
32.	黄丹华. 低温等离子手术治疗儿童腺样体肥大的疗效分析. 生命科学仪器. 2024(05): 161-162+165 .
33.	张良. 低温等离子手术治疗扁桃体腺样体肥大的临床效果分析. 基层医学论坛. 2024(28): 57-59 .
34.	高洁，陈娟，邱宏，曾鸣辉，饶琰. CICARE沟通模式在儿童扁桃体腺样体术前访视中的应用. 中国医学创新. 2024(28): 91-95 .
35.	李敬，朱新炜，黄波，张华，臧睿. 低吗啡综合镇痛方式在术后镇痛领域的临床应用. 科技导报. 2024(19): 113-118 .
36.	袁翠云，陈莉. 低温等离子扁桃体切除术后再出血的高危因素及预防性策略分析. 全科护理. 2024(22): 4334-4337 .
37.	刘益建，王军民，孙浩，刘昱秀，周辉. 加减疏风清热汤在扁桃体伴腺样体肥大切除术中的应用. 辽宁中医杂志. 2024(11): 103-106 .
38.	李界文，刘小晶，吴献林. 0°鼻内镜下经口鼻联合进路动力系统配合低温等离子切除术治疗小儿扁桃体及腺样体肥大的效果及对患儿疼痛、炎症反应的影响. 中国实用医药. 2024(21): 65-67 .
39.	王玲玲. 基于临床护理路径的围术期护理对低温等离子切除术的扁桃体腺样体肥大患儿的临床效果观察. 现代养生. 2024(23): 1790-1792 .
40.	蔡继壹，林炳煌，王少将，孙佳琳，彭凤雪. TCRF与ETA治疗腺样体肥大患者的效果观察. 中国医疗器械信息. 2024(22): 66-68 .
41.	张明德，张秋敏. 低温等离子射频消融术对扁桃体腺样体肥大患儿疼痛程度、发音参数的影响. 反射疗法与康复医学. 2024(13): 52-55 .
42.	缪陶林，韩晓雨. 艾司氯胺酮对采用低温等离子手术治疗的腺样体肥大患儿苏醒期躁动及疼痛程度的影响. 反射疗法与康复医学. 2024(13): 99-102 .
43.	李杰才，黄晓莲，温柏林. 腺样体非轮廓化切除术与轮廓化切除术的对比分析. 系统医学. 2024(22): 89-92 .
44.	敖红敏，余子兰，钟康华，李桃根，张丽卫. 改良低温等离子法对扁桃体切除患者围手术期指标、血清炎症因子及生活质量的影响. 中国医学创新. 2024(36): 34-38 .
45.	邱科金，朱炼兵，丁雅婷，蔡金钰，谢树居. 低温等离子射频消融术联合不同温度盐水鼻腔冲洗在腺样体肥大患儿治疗中的应用效果. 中国卫生标准管理. 2024(23): 27-30+35 .
46.	崔晓敏. 预防性应用艾司氯胺酮在行扁桃体、腺样体切除术患儿中的价值分析. 实用中西医结合临床. 2023(02): 97-99+107 .
47.	魏锋. 鼻内镜下动力系统与低温等离子消融术在儿童腺样体手术中的疗效比较. 名医. 2023(03): 72-74 .
48.	张群，陈明清. 低温等离子系统联合腺样体扁桃体切除术在阻塞性睡眠呼吸暂停低通气综合征患儿中的应用分析. 中国校医. 2023(05): 369-372 .
49.	刘晓峰，杜娟，王登茂，王亚芳，崔莉，宋英鸾，耿江桥. 血清白三烯C4、D4及C-C趋化因子配体21水平与腺样体肥大患儿腺样体肥大程度及预后的相关性. 川北医学院学报. 2023(07): 927-930 .
50.	牛海珍，黄辉，解凤磊，王少华，潘瑞，盖莹莹，李梦思. 4～8℃生理盐水对等离子辅助下扁桃体腺样体切除患儿出血和疼痛的影响. 安徽医学. 2023(07): 848-851 .
51.	甘育涛，陈佳青，彭攀. 氢吗啡酮与布托啡诺静脉自控镇痛对骨科术后患者疼痛递质、炎性因子及氧化应激反应的影响比较. 临床合理用药. 2023(21): 114-117 .
52.	李正民，郑碧云，梁珍婵. 玉屏风散颗粒联合孟鲁司特钠与糠酸莫米松鼻喷雾治疗腺样体肥大的效果. 中国当代医药. 2023(20): 143-146 .
53.	曹文慧，高英英，雷永超，黄亦男. 鼻内镜下低温等离子切除术对鼾症患儿临床症状的影响及安全性分析. 现代医学与健康研究电子杂志. 2023(16): 10-12 .
54.	刘冰，王德霖. 扁桃体腺样体肥大患儿使用低温等离子扁桃体腺样体切除术进行治疗的临床效果. 中国医学文摘(耳鼻咽喉科学). 2023(05): 17-20 .
55.	郑昌华. 以家庭为中心的护理模式在内镜下鼻腺样体肥大切除术后患儿中的应用. 中国医药指南. 2023(27): 184-186 .
56.	王晶，王晓莹，吴倩. 专项护理联合疼痛干预在行日间手术扁桃体腺样体肥大患儿中的应用. 中西医结合护理(中英文). 2023(09): 73-75 .
57.	郭帅. 低温等离子射频消融术治疗儿童扁桃体腺样体肥大的效果. 中国民康医学. 2023(21): 57-60 .
58.	杨子璐. 鼻咽部CT对儿童腺样体肥大和病情程度的诊断价值. 影像研究与医学应用. 2023(18): 63-65 .
59.	周东杰，郝永波. 分析鼻内镜下动力系统腺样体切除术在腺样体肥大患儿中的应用效果. 系统医学. 2023(17): 60-63 .
60.	王智勇，朱峰，梁滔，夏利辉，莫平. 小儿扁桃体低温等离子射频切除术行ERAS对患儿VAS及血清免疫球蛋白的影响. 中国医师杂志. 2023(12): 1815-1819 .
61.	赵月菊，历建强. 低温等离子扁桃体切除术对慢性扁桃体炎患者的治疗有效性研究. 中外医疗. 2023(31): 37-40 .
62.	孙成营. 鼻内镜下低温等离子消融术治疗腺样体肥大的效果研究. 中华养生保健. 2023(13): 46-49 .
63.	陈晓觉. 鼻内镜下低温等离子切除术治疗腺样体肥大患儿的疗效. 中国医疗器械信息. 2022(22): 52-54 .

Other cited types(1)

Get Citation

PDF

XML

Article views (154) PDF downloads (8) Cited by(64)

Turn off MathJax

Article Contents

Abstract

References

Clinical observation of Shouwu Huoxue Granules combined with dual antiplatelet in treatment of large atherosclerotic cerebral infarction

Abstract

References

Related Articles

Cited by

Periodical cited type(63)

Other cited types(1)

Catalog

Clinical observation of Shouwu Huoxue Granules combined with dual antiplatelet in treatment of large atherosclerotic cerebral infarction

Abstract

References

Related Articles

Cited by

Periodical cited type(63)

Other cited types(1)

Catalog

Export File

Citation

Format

Content